Medifast/MED

$40.73

1.82%
-
1D1W1MYTD1YMAX

About Medifast

Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.
Ticker
MED
Sector
Consumer Non-Cyclicals
Trading on
NYSE
Industry
Biotechnology & Drugs
CEO
Daniel Chard
Employees
634
Headquarters
Owings mills, United States

Medifast Metrics

BasicAdvanced
$443.78M
Market cap
4.47
P/E ratio
$9.11
EPS
1.18
Beta
$4.95
Dividend rate

What the Analysts think about Medifast

Analyst Ratings

Majority rating from 2 analysts.
Hold

Price Targets

Average projection from 2 analysts.
53.45% upside
High $67.00
Low $58.00
$40.73
Current price
$62.50
Average price target

Medifast Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
3.14% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$191M
-19%
Net income
$6M
-74.03%
Profit margin
3.14%
-67.93%

Medifast Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 99.06%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q1 24
Actual
$3.67
$2.77
$2.12
-
Expected
$2.40
$1.44
$1.07
$0.78
Surprise
53.04%
92.36%
99.06%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Medifast stock

Buy or sell Medifast stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing